Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference

Fri Feb 15, 2013 8:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130215:nPnLA60987


UNION CITY, Calif.,  Feb. 15, 2013  /PRNewswire/ -- Abaxis, Inc. (NasdaqGS:
ABAX), a medical products company manufacturing point-of-care blood analysis
systems, announced today that  Don Wood, Chief Operations Officer, will
participate in the Lazard Capital Markets 5th  Annual Medical Technology
Snowbird Conference.

The event is being held from  February 27 - March 1, 2013  at The Cliff Hotel,
Snowbird Ski and Summer Resort in  Snowbird, Utah. The conference format
consists of a full day of one-on-one meetings and will not be webcast.

Institutional investors that wish to request a meeting with Abaxis, Inc. should
contact Lazard Capital Markets.

About Abaxis

Abaxis develops, manufactures, markets and sells portable blood analysis systems
for use in any veterinary or human patient-care setting to provide clinicians
with rapid blood constituent measurements.  The system consists of a compact,
5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs that contain all the chemicals required to perform a
panel of up to 13 tests on veterinary patients and 14 tests on human patients. 
The system can be operated with minimal training and performs multiple routine
tests on whole blood, serum or plasma samples.  The system provides test results
in less than 12 minutes with the precision and accuracy equivalent to a clinical
laboratory analyzer.  The veterinary business also provides to the animal health
and research market a line of hematology instruments for point-of-care complete
blood counts (CBC), a specialty instrument to screen for and detect clotting
disorders and to measure equine fibrinogen levels, a handheld instrument for the
rapid assessment of certain critical care tests and rapid point-of-care tests
for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through
its AVRL division, provides routine laboratory testing as well as specialty
testing for veterinarians nationwide.

 Contact:  Abaxis, Inc.             Lytham Partners, LLC                  
           Clint Severson           Joe Dorame, Robert Blum and Joe Diaz  
           Chief Executive Officer  602-889-9700                          
           510-675-6500             


SOURCE  Abaxis, Inc.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.